LeMaitre Vascular, Inc.
General ticker "LMAT" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.0B (TTM average)
LeMaitre Vascular, Inc. follows the US Stock Market performance with the rate: 24.5%.
Estimated limits based on current volatility of 1.7%: low 82.14$, high 84.97$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-08-21, amount 0.20$ (Y0.93%)
- Total employees count: 664 (+5.4%) as of 2024
- US accounted for 58.6% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market competition, Acquisition/divestiture risks, Pricing pressures, Market acceptance, Regulatory and compliance
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [79.68$, 113.65$]
- 2025-12-31 to 2026-12-31 estimated range: [80.40$, 115.89$]
Financial Metrics affecting the LMAT estimates:
- Negative: with PPE of 47.6 at the end of fiscal year the price was very high
- Positive: Operating profit margin, % of 23.77 > 18.64
- Positive: -14.38 < Investing cash flow per share per price, % of -9.66
- Positive: Return on assets ratio (scaled to [-100,100]) of 7.39 > 6.04
- Positive: 0 < Industry operating cash flow per share per price (median), % of 0.78
- Negative: Operating cash flow per share per price, % of 2.13 <= 6.82
- Positive: Inventory ratio change, % of -1.01 <= -0.75
- Positive: 41.86 < Shareholder equity ratio, % of 61.12 <= 63.39
Short-term LMAT quotes
Long-term LMAT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $161.65MM | $193.48MM | $219.86MM |
| Operating Expenses | $134.82MM | $156.77MM | $167.61MM |
| Operating Income | $26.83MM | $36.71MM | $52.26MM |
| Non-Operating Income | $0.66MM | $2.76MM | $4.62MM |
| Interest Expense | $0.00MM | $0.00MM | $0.20MM |
| R&D Expense | $13.29MM | $16.97MM | $15.65MM |
| Income(Loss) | $27.49MM | $39.48MM | $56.88MM |
| Taxes | $6.85MM | $9.37MM | $12.84MM |
| Profit(Loss)* | $20.64MM | $30.11MM | $44.04MM |
| Stockholders Equity | $268.20MM | $297.90MM | $337.29MM |
| Inventory | $45.28MM | $52.33MM | $55.94MM |
| Assets | $310.48MM | $346.78MM | $551.82MM |
| Operating Cash Flow | $25.38MM | $36.75MM | $44.12MM |
| Capital expenditure | $3.23MM | $7.26MM | $6.96MM |
| Investing Cash Flow | $-10.37MM | $-24.71MM | $-200.12MM |
| Financing Cash Flow | $-9.23MM | $-7.13MM | $158.10MM |
| Earnings Per Share** | $0.94 | $1.36 | $1.96 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.